A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...
A landmark Oxford-led analysis of 1.8 million people has found that non-meat diets significantly slash the risk of several cancers, including a 31% drop in multiple myeloma.